As of Jun 23
| +0.19 / +2.41%|
The 6 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 13.62, with a high estimate of 20.00 and a low estimate of 10.44. The median estimate represents a +68.84% increase from the last price of 8.07.
The current consensus among 6 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.